Literature DB >> 360837

Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease.

W M Bennett, F Kloster, J Rosch, J Barry, G A Porter.   

Abstract

Arteriosclerotic heart disease is a major cause of death in insulin-requiring juvenile diabetic patients treated for end-stage renal disease. Eleven consecutive diabetic patients without clinical evidence of coronary artery disease underwent complete cardiac evaluations, including coronary arteriography, as part of transplant recipient work-ups. Seven were women and four were men; their mean age was 32 (21 to 50 years). Angiographically, every patient had multifocal atherosclerotic coronary disease. Four of seven patients tested had positive-stress electrocardiograms. In this group of patients followed for a mean of 19.8 months, eight died. Of these deaths, six were due to coronary heart disease and another due to a stroke. In two patients who became clinically symptomatic, serial angiograms revealed progressive disease of the coronary circulation; in one case, despite normal renal allograft function and serum lipid levels. The mode of end-stage renal disease treatment, serum lipids or blood pressure control could not be linked to mortality. It is concluded that arteriosclerotic heart disease is common in diabetic patients with end-stage renal disease even when angina is absent. The natural history in this high risk population is an important consideration in the selection of patients for end-stage renal disease treatment.

Entities:  

Mesh:

Year:  1978        PMID: 360837     DOI: 10.1016/0002-9343(78)90796-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

Review 1.  Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

Authors:  M J Sarnak; A S Levey
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

Review 2.  Cardiac testing for coronary artery disease in potential kidney transplant recipients.

Authors:  Louis W Wang; Magid A Fahim; Andrew Hayen; Ruth L Mitchell; Laura Baines; Stephen Lord; Jonathan C Craig; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

3.  The treatment of diabetic kidney disease.

Authors:  F C Goetz; C M Kjellstrand
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

4.  Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease.

Authors:  Alan S Go; Nisha Bansal; Malini Chandra; Phenius V Lathon; Stephen P Fortmann; Carlos Iribarren; Chi-Yuan Hsu; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2011-10-04       Impact factor: 24.094

5.  Coronary bypass surgery in a renal transplant patient.

Authors:  T Tezcaner; C Yorgancioğlu; O Moldibi; Z Catav; B Erbay; I Y Zorlutuna
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

6.  Screening for coronary artery disease in kidney transplant candidates.

Authors:  Dana V Rizk; Samy Riad; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2014-10-09       Impact factor: 5.952

Review 7.  Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.

Authors:  Krista L Lentine; Frank P Hurst; Rahul M Jindal; Todd C Villines; Jeffrey S Kunz; Christina M Yuan; Paul J Hauptman; Kevin C Abbott
Journal:  Am J Kidney Dis       Date:  2009-09-23       Impact factor: 8.860

8.  Cardiac function during stress testing in long-standing insulin-dependent diabetics.

Authors:  A D Harrower; G McFarlane; P Parekh; K Young; R Railton
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

9.  Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA.

Authors:  Dipen S Parikh; Madhav Swaminathan; Laura E Archer; Jula K Inrig; Lynda A Szczech; Andrew D Shaw; Uptal D Patel
Journal:  Nephrol Dial Transplant       Date:  2010-01-26       Impact factor: 5.992

10.  Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.